XRTX logo

XORTX Therapeutics (XRTX)

Profile

Full Name

XORTX Therapeutics Inc.

Ticker Symbol

XRTX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Canada

IPO

September 23, 2021

Indexes

Not included

Website

http://www.xortx.com

Employees

2

Key Details

Price

$0.94(+4.33%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.15(-5.50% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.94
XRTX price is $0.94

30-Day Relative Volume

0.98
XRTX 30-day relative volume is 0.98

Price Performance

Price Today change

+4.33%
XRTX price is up +4.33% today

Price YTD change

-16.9%
XRTX price is down -16.9% since January 1st

Price 1-year change

-69.71%
XRTX price is down -69.71% year-on-year

Price 3-year change

-99.39%
XRTX price is down -99.39% over the past 3 years

Price Range

Price All-time high

$495.72
XRTX price is currently -99.81% below its historical high of $495.72

Price 3-year low

$0.80
XRTX price is currently +17.08% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$3.56M
XRTX market capitalization is $3.56 million

Market cap 3-year change

-98.39%
XRTX market capitalization is down -98.39% over the past 3 years

Market cap All-time high

$501.15M
XRTX market capitalization is currently -99.29% below its historical high of $501.15 million

Market cap sector rank

10.03%
XRTX market capitalization is higher than 10.03% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+30.47%
XRTX shares outstanding is up +30.47% year-on-year

Shares Outstanding 3-Year Change

+162.47%
XRTX shares outstanding is up +162.47% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.43
XRTX beta is 0.43

200-day SMA

$1.34
XRTX price is currently -30.18% below its 200-day simple moving average

50-day SMA

$0.93
XRTX price is currently +0.63% above its 50-day simple moving average

RSI

47.43
XRTX 14-day relative strength index is 47.43

Volume

0.98
XRTX 30-day relative volume is 0.98

ATR

$0.08
XRTX average true range is $0.08

10-day Historical Volatility

72.59%
XRTX 10-day historical volatility is 72.59%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
XRTX annual revenue value is unknown

Revenue Analysts estimate

-
XRTX annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
XRTX annual revenue 1-year change is unknown

Revenue Sector rank

-
XRTX annual revenue is unknown

EPS

EPS

-$1.15
XRTX annual earnings per share is -$1.15

EPS Analysts estimate

-$1.57
XRTX annual earnings per share is currently -26.94% lower than the consensus analysts' forecast

EPS 1-year change

-5.5%
XRTX annual earnings per share is down -5.5% year-on-year

EPS Sector rank

53.27%
XRTX annual earnings per share is higher than 53.27% of companies in Healthcare sector

Profit

Gross profit

-
XRTX annual gross profit value is unknown

Gross margin

-
XRTX annual gross profit margin value is unknown

Operating profit

-$4.12M
XRTX annual operating income is -$4.12 million

Operating margin

-
XRTX annual operating profit margin value is unknown

Net income

-$3.31M
XRTX annual net profit is -$3.31 million

Net margin

-
XRTX annual net profit margin value is unknown

Expenses

Total expenses

$4.12M
XRTX annual total expenses is $4.12 million

Operating expenses

$4.12M
XRTX annual total operating expenses is $4.12 million

Cost of goods sold

-
XRTX annual cost of goods sold value is unknown

Selling, general & administrative expenses

$2.28M
XRTX annual SGA is $2.28 million

Depreciation and amortization

$117.30K
XRTX annual depreciation & amortization is $117.30 thousand

Interest expense

-
XRTX annual interest expense value is unknown

Income tax

-
XRTX annual income tax value is unknown

EBIT & EBITDA

EBIT

-$4.12M
XRTX annual earnings before interest & taxes is -$4.12 million

EBITDA

-$4.00M
XRTX annual EBITDA is -$4.00 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$4.09M
XRTX annual total assets is $4.09 million

Non current assets

$1.42M
XRTX annual long term assets is $1.42 million

Current assets

$2.68M
XRTX annual total current assets is $2.68 million

Cash and cash equivalents

$2.47M
XRTX annual cash & cash equivalents is $2.47 million

Accounts receivable

$17.60K
XRTX annual accounts receivable is $17.60 thousand

Inventory

-
XRTX annual inventory value is unknown

Liabilities

Total liabilities

$758.00K
XRTX annual total liabilities is $758.00 thousand

Long term liabilities

$0.00
XRTX annual total long term liabilities is $0.00

Current liabilities

$758.00K
XRTX annual total current liabilities is $758.00 thousand

Accounts payable

$84.00K
XRTX annual accounts payable is $84.00 thousand

Debt

Total debt

$38.80K
XRTX annual total debt is $38.80 thousand

Total debt 1-year change

+237.39%
XRTX annual total debt is up +237.39% year-on-year

Long term debt

-
XRTX annual long term debt value is unknown

Short term debt

$38.80K
XRTX annual short term debt is $38.80 thousand

Equity & Capital

Shareholders equity

$3.34M
XRTX annual stockholders equity is $3.34 million

Book value

$3.34M
XRTX annual book value is $3.34 million

Retained earnings

-$21.17M
XRTX annual retained earnings is -$21.17 million

Working capital

$1.92M
XRTX annual working capital is $1.92 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$3.68M
XRTX annual cash flow from operations is -$3.68 million

Cash from operations 1-year change

+44.12%
XRTX annual cash flow from operations is up +44.12% year-on-year

Cash from investing

-$38.90K
XRTX annual cash flow from investing activities is -$38.90 thousand

Cash from investing 1-year change

+16.16%
XRTX annual cash flow from investing activities is up +16.16% year-on-year

Cash from financing

$2.78M
XRTX annual cash flow from financing activities is $2.78 million

Cash from financing 1-year change

+869.94%
XRTX annual cash flow from financing activities is up +869.94% year-on-year

CAPEX

CAPEX

-
XRTX annual capital expenditures value is unknown

CAPEX 1-year change

-
XRTX annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$3.72M
XRTX annual free cash flow is -$3.72 million

Free cash flow 1-year change

+43.92%
XRTX annual free cash flow is up +43.92% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
XRTX annual gross profit margin value is unknown

Operating margin

-
XRTX annual operating profit margin value is unknown

Net margin

-
XRTX annual net profit margin value is unknown

ROA & ROE

ROA

-80.92%
XRTX annual return on assets is -80.92%

ROE

-99.30%
XRTX annual return on equity is -99.30%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
XRTX price to earnings ratio value is unknown

PE ratio Sector rank

-
XRTX price to earnings ratio is unknown

PB Ratio

PB ratio

1.07
XRTX price to book ratio is 1.07

PB ratio Sector rank

45.84%
XRTX price to book ratio is higher than 45.84% of companies in Healthcare sector

PS Ratio

PS ratio

-
XRTX price to sales ratio value is unknown

PS ratio Sector rank

-
XRTX price to sales ratio is unknown

Enterprise value

Enterprise value

$1.12M
XRTX enterprise value is $1.12 million

Enterprise value Sector rank

14.06%
XRTX enterprise value is higher than 14.06% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.28
XRTX EV/EBITDA is -0.28

EV/EBITDA Sector rank

56.66%
XRTX EV/EBITDA is higher than 56.66% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.53
XRTX annual current ratio is 3.53

Quick ratio

-
XRTX annual quick ratio value is unknown

Leverage

Debt to equity

0.01
XRTX annual debt to equity ratio is 0.01

Interest coverage ratio

-
XRTX annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
XRTX piotroski f-score value is unknown

Altman Z-Score

-
XRTX altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Dec 22, 21 Alliance Global Partners
Buy
Dec 9, 21 Alliance Global Partners
Buy

Institutional Ownership

Similar stocks

TTNP logo
Titan Pharmaceuticals (TTNP)
GLTO logo
Galecto (GLTO)
NBY logo
NovaBay Pharmaceuticals (NBY)
ARTL logo
Artelo Biosciences (ARTL)
ATNF logo
180 Life Sciences (ATNF)
QNRX logo
Quoin Pharmaceuticals (QNRX)
INM logo
InMed Pharmaceuticals (INM)
JAGX logo
Jaguar Health (JAGX)
HSCS logo
Heart Test Laboratories (HSCS)
  • What is the ticker symbol for XORTX Therapeutics?
  • Does XORTX Therapeutics pay dividends?
  • What sector is XORTX Therapeutics in?
  • What industry is XORTX Therapeutics in?
  • What country is XORTX Therapeutics based in?
  • When did XORTX Therapeutics go public?
  • Is XORTX Therapeutics in the S&P 500?
  • Is XORTX Therapeutics in the NASDAQ 100?
  • Is XORTX Therapeutics in the Dow Jones?
  • When does XORTX Therapeutics report earnings?
  • Should I buy XORTX Therapeutics stock now?

What is the ticker symbol for XORTX Therapeutics?

The ticker symbol for XORTX Therapeutics is NASDAQ:XRTX

Does XORTX Therapeutics pay dividends?

No, XORTX Therapeutics does not pay dividends

What sector is XORTX Therapeutics in?

XORTX Therapeutics is in the Healthcare sector

What industry is XORTX Therapeutics in?

XORTX Therapeutics is in the Biotechnology industry

What country is XORTX Therapeutics based in?

XORTX Therapeutics is headquartered in Canada

When did XORTX Therapeutics go public?

XORTX Therapeutics's initial public offering (IPO) was on September 23, 2021

Is XORTX Therapeutics in the S&P 500?

No, XORTX Therapeutics is not included in the S&P 500 index

Is XORTX Therapeutics in the NASDAQ 100?

No, XORTX Therapeutics is not included in the NASDAQ 100 index

Is XORTX Therapeutics in the Dow Jones?

No, XORTX Therapeutics is not included in the Dow Jones index

When does XORTX Therapeutics report earnings?

The date for XORTX Therapeutics's next earnings report has not been announced yet

Should I buy XORTX Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page